Case of the month - August 2007 - discussion
Diagnosis - Metaplastic Carcinoma
- The thumbnail images alongside remind you of the main features in this biopsy - click on each thumbnail to return to the original images.
- The following features are seen:
- A dominant malignant spindle cell component
- Scattered nests of malignant epithelial cells showing glandular and squamoid differentiation
- Both epithelial and some of the spindle cell elements stain with epithelial markers
- The tumour is strongly CK5/6 positive indicating a basal cell phenotype - see reference
- The co-expression of CK7 & CK5/6 in this case is worthy of comment. These tumours commonly show 'basal' characteristics and the distinction between 'luminal' and 'basal' types is not always as clear-cut as we would like
- The tumour was also shown to be ER negative - a frequent finding in these cancers
- As a practice point if you are ever presented with a biopsy showing either a wholly or predominantly spindle cell lesion in the breast you should do two things:
- Look hard for an epithelial component including taking extra blocks from an excision
- Use immunohistochemistry to see whether the spindle cell element expresses (even patchily) epithelial markers - CK5/6 is the most reliable in our hands
- The WHO classification defines this tumour as follows:
- A heterogeneous group of neoplasms generally characterised by an intimate admixture of adenocarcinoma with dominant areas of
spindle cell, squamous, and/or mesenchymal differentiation....... and that the metaplastic spindle cell and squamous cell carcinomas
may present in a pure form without any recognizable adenocarcinoma
- The following subclassification is recommended by the WHO:
- Epithelial tumours with spindle cell differentiation including:
- Squamous cell carcinoma
- Adenocarcinoma with spindle cell differentiation
- Adenosquamous carcinoma (including mucoepidermoid carcinoma)
- Mixed epithelial/mesenchymal tumours:
- Mixed epithelial and mesenchymal tumours e.g. showing chondroid or osseous differentiation
- Carcinosarcoma
Prognosis
- Axillary node metastases are relatively rare in metaplastic carcinomas - 10-30% of cases
- It is difficult to generalise about overall survival because different series tend to report different case mixes
- An overall 5 year survival of about 60% is a reasonable estimate
- After adjustment for tumour size and node status, metaplastic carcinomas probably have a better survival than their ductal counterparts
Reference: